Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca, Pfizer-BioNTech's COVID-19 Jabs Work Well With Moderna Shot, UK Study Says

12/06/2021 | 10:32pm EST


ę MT Newswires 2021
All news about PFIZER, INC.
01/22Pfizer CEO sees annual COVID vaccine rather than frequent boosters
RE
01/22Tokyo hits record 10,000 COVID cases, Japan over 50,000 for first time
RE
01/22Tokyo hits record 10,000 COVID cases, Japan over 50,000 for first time
RE
01/21Pzifer, OPKO Health Evaluating FDA's Complete Response Letter on Growth Hormone Replace..
MT
01/21Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for ..
BU
01/21Pfizer Inc. and OPKO Health, Inc. Provide Update on the Biologics License Application f..
CI
01/21Moderna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities S..
MT
01/21Boosters provide 'added protection' against Omicron -CDC
RE
01/21Small children getting less sick from Omicron; Genetic mutation protects against severe..
RE
01/21Booster shots needed against omicron, CDC studies show
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 972 M - -
Net income 2021 22 216 M - -
Net Debt 2021 27 397 M - -
P/E ratio 2021 13,8x
Yield 2021 3,00%
Capitalization 296 B 296 B -
EV / Sales 2021 3,95x
EV / Sales 2022 3,12x
Nbr of Employees 78 500
Free-Float -
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 52,79 $
Average target price 57,79 $
Spread / Average Target 9,46%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-10.60%296 303
JOHNSON & JOHNSON-3.40%434 036
ROCHE HOLDING AG-4.87%319 830
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-11.98%220 356
NOVO NORDISK A/S-14.11%219 146